Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09KLR
|
||||
Former ID |
DAP000182
|
||||
Drug Name |
Alendronate
|
||||
Synonyms |
Arendal; Fosamax; ALENDRONATE SODIUM; ALENDRONIC ACID; Acide alendronique; Acido alendronico; Acidum alendronicum; MK 217; Acide alendronique [INN-French]; Acido alendronico [INN-Spanish]; Acidum alendronicum [INN-Latin]; Alendronic acid (INN); Alendronic acid [INN:BAN]; Bisphosphonate, 65; Fosamax (TN); MK-217; Phosphonic acid, (4-amino-1-hydroxybutylidene)bis; (4-Amino-1-hydroxybutylidene)bisphosphonic acid; (4-Amino-1-hydroxybutylidene)diphosphonic acid; (4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid; (4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid); 4-Amino-1-hydroxybutane-1,1-diphosphonate; 4-Amino-1-hydroxybutane-1,1-diphosphonic Acid; 4-Amino-1-hydroxybutylidene-1,1-bis(phosphonic acid); 4-Amino-1-hydroxybutylidene-1,1-bisphosphonate
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Bone Density Conservation Agents
|
||||
Company |
Teva Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C4H13NO7P2
|
||||
Canonical SMILES |
C(P(=O)(O)[O-])(P(=O)(O)O)(O)CCCN.[Na+].O.O.O
|
||||
InChI |
InChI=1S/C4H13NO7P2/c5-3-1-2-4(6,13(7,8)9)14(10,11)12/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12)
|
||||
InChIKey |
OGSPWJRAVKPPFI-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 66376-36-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9954, 649130, 7344414, 7978659, 8151420, 10318378, 15196679, 26612802, 26750071, 29215185, 29215186, 29221268, 46393653, 46507199, 47291221, 48110541, 48415528, 50007414, 50659878, 51091458, 53790851, 53801179, 56374454, 57321131, 87560297, 93166338, 103228757, 104299568, 105562999, 118402569, 125645927, 126524218, 126685342, 127330008, 127330009, 127330010, 127330011, 127330012, 127330186, 127330187, 127330188, 127330189, 128806596, 131322978, 131349593, 134337502, 135007310, 135366402, 135649795, 136991069
|
||||
ChEBI ID |
ChEBI:2567
|
||||
SuperDrug ATC ID |
M05BA04
|
||||
SuperDrug CAS ID |
cas=066376361
|
||||
Target and Pathway | |||||
Target(s) | Farnesyl pyrophosphate synthase | Target Info | Modulator | [556264] | |
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Cholesterol biosynthesis | ||||
References | |||||
Ref 536664 | Osteonecrosis of the jaw. South Med J. 2008 Feb;101(2):160-5. | ||||
Ref 540141 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3141). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.